Bicycle Therapeutics Plc - ADR
BCYC
Market Cap$502.37M
Close$
$-24.32
206.3% downside
Current Fair Value
206.3% downsideOvervalued by 206.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $502.37 Million |
|---|---|
| Enterprise Value | $84.22 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-4.34 |
| Beta | 0.88 |
| Outstanding Shares | 21,304,801 |
| Avg 30 Day Volume | 329,836 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.99 |
|---|---|
| PEG | 9.34 |
| Price to Sales | 22.89 |
| Price to Book Ratio | 1.43 |
| Enterprise Value to Revenue | 2.02 |
| Enterprise Value to EBIT | -0.47 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 0.11 |
Revenue Sources
No data
ESG Score
No data
About Bicycle Therapeutics Plc
CEO: Kevin Lee